COVID-19 small phase 1 trial vaccine proves safe in older adults

Small phase 1 trial demonstrates safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.
Small phase 1 trial demonstrates safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.